The protective efficacy aganist Schistosoma japonicum infection by immunization with DNA vaccine and levamisole as adjuvant in mice

Vaccine

Volumn 26, Issue 15, 2008, Pages 1832-1845

  Wang, Xiao ^a   Jin, Huali ^a   Du, Xiaogang ^a   Cai, Chun ^b   Yu, Yang ^a   Zhao, Gan ^a   Su, Baowei ^a   Huang, Shan ^a   Hu, Yanxin ^a   Luo, Dongmei ^a   She, Ruiping ^a   Luo, Xinsong ^c   Zeng, Xianfang ^b   Yi, Xinyuan ^b   Wang, Bin ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Central South University   (China)

^c Hunan Institute of Schistosomiasis Control   (China)

Author keywords

DNA vaccine; Gramulomas formation; Immune response; Levamisole; Schistosoma japonicum

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; LEVAMISOLE; PROTEIN BAX; PROTEIN BCL 2; HELMINTH ANTIBODY; IMMUNOLOGICAL ADJUVANT; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY; LIVER FIBROSIS; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; ANIMAL; BLOOD; C57BL MOUSE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LIVER; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; LEVAMISOLE; LIVER; MICE; MICE, INBRED C57BL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; T-LYMPHOCYTE SUBSETS; TH1 CELLS; VACCINES, DNA;

EID: 40849107811     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.01.056     Document Type: Article

References (48)

1. Zhu Y., Si J., Harn D.A., Xu M., Ren J., Yu C., et al. Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection. Parasitology 132 1 (2006) 67-71
2. Schwartz E., Rozenman J., Bhigjee A., Halkic N., Gintzburger D., Bartley P.B., et al. Schistosomiasis. N Engl J Med 347 10 (2002) 766-768
3. Ross A.G.P., Sleigh A.C., Li Y., Davis G.M., Williams G.M., Jiang Z., et al. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clin Microbiol Rev 14 2 (2001) 270-295
4. Harder A. Chemotherapeutic approaches to Schistosomes: current knowledge and outlook. Parasitol Res 88 5 (2002) 395-397
5. Chitsulo L., Engels D., Montresor A., and Savioli L. The global status of schistosomiasis and its control. Acta Trop 77 1 (2000) 41-51
6. Moloney N.A., Bickle Q.D., and Webbe G. The induction of specific immunity against Schistosoma japonicum by exposure of mice to ultraviolet attenuated cercariae. Parasitology 90 Pt 2 (1985) 313-323
7. Da'dara A.A., Skelly P.J., Fatakdawala M., Visovatti S., Eriksson E., and Harn D.A. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery. Parasite Immunol 24 4 (2002) 179-187
8. Argiro L., Henri S., Dessein H., Dessein A.J., and Bourgois A. Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum. Vaccine 17 1 (1999) 13-18
9. Cai C., Yi X., Zeng X., Zhou J., and Shu X. Schistosoma japonicum: protective immunity induced in mice immunized with SjGST-Sj32. Hunan Yi Ke Da Xue Xue Bao 24 3 (1999) 225-228
10. Chlichlia K., Bahgat M., Ruppel A., and Schirrmacher V. DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine 20 3-4 (2001) 439-447
11. Kang Y., Jin H., Zheng G., Xie Q., Yin J., Yu Y., et al. The adjuvant effect of levamisole on killed viral vaccines. Vaccine 23 48-49 (2005) 5543-5550
12. Fonseca C.T., Brito C.F., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22 3-4 (2004) 503-510
13. Jin H., Li Y., Ma Z., Zhang F., Xie Q., Gu D., et al. Effect of chemical adjuvants on DNA vaccination. Vaccine 22 21-22 (2004) 2925-2935
14. Laurie J.A., Moertel C.G., Fleming T.R., Wieand H.S., Leigh J.E., Rubin J., et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7 10 (1989) 1447-1456
15. Zhang R., Yi X., Zeng X., Zhang S., and McReynolds L. DNA vaccines of VR10122SjGST and VR1012-SjGST-Sj32: expression and protective immunity in mice. J Hunan Normal Univ (Med Sci) 1 1 (2004) 5-8
16. Dupre L., Kremer L., Wolowczuk I., Riveau G., Capron A., and Locht C. Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection. Vaccine 19 11-12 (2001) 1373-1380
17. Nascimento E.J., Amorim R.V., Cavalcanti A., Alves V.F., Nakazawa M., Pereira V.R., et al. Assessment of a DNA vaccine encoding an anchored-glycosylphosphatidylinositol tegumental antigen complexed to protamine sulphate on immunoprotection against murine schistosomiasis. Mem Inst Oswaldo Cruz 102 1 (2007) 21-27
18. Lyons A.B., and Parish C.R. Determination of lymphocyte division by flow cytometry. J Immunol Methods 171 1 (1994) 131-137
19. Du X., Zheng G., Jin H., Kang Y., Wang J., Xiao C., et al. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 9 2 (2007) 136-146
20. Fallon P.G., and Dunne D.W. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J Immunol 162 7 (1999) 4122-4132
21. Yin J., Jin H., Kang Y., Xiao C., Zhao L., Li X., et al. Efficacy of modified levamisole adjuvant on inactivated virus vaccine. Viral Immunol 19 3 (2006) 525-535
22. Belardelli F. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103 3 (1995) 161-179
23. Heydtmann M., Shields P., McCaughan G., and Adams D. Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis 14 3 (2001) 279-287
24. Kang J., and Der S.D. Cytokine functions in the formative stages of a lymphocyte's life. Curr Opin Immunol 16 2 (2004) 180-190
25. Hesse M., Cheever A.W., Jankovic D., and Wynn T.A. NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol 157 3 (2000) 945-955
26. Wynn T.A., Oswald I.P., Eltoum I.A., Caspar P., Lowenstein C.J., Lewis F.A., et al. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 153 11 (1994) 5200-5209
27. Mountford A.P., Anderson S., and Wilson R.A. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol 156 12 (1996) 4739-4745
28. Demirci F., Bayraktaroglu Z., Karaoglan M., Coskun Y., Karaoglan I., and Okan V. Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children. Turk J Gastroenterol 16 4 (2005) 188-193
29. Bozic F., Lackovic G., Kovsca-Janjatovic A., Smolec O., and Valpotic I. Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs. J Vet Pharmacol Ther 29 3 (2006) 199-204
30. Cook R.M., Carvalho-Queiroz C., Wilding G., and LoVerde P.T. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 72 10 (2004) 6112-6124
31. Pancre V., Wolowczuk I., Guerret S., Copin M.C., Delanoye A., Capron A., et al. Protective effect of rSm28GST-specific T cells in schistosomiasis: role of gamma interferon. Infect Immun 62 9 (1994) 3723-3730
32. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., and Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol 154 9 (1995) 4701-4709
33. Chiaramonte M.G., Hesse M., Cheever A.W., and Wynn T.A. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J Immunol 164 2 (2000) 973-985
34. Metwali A., Elliott D., Blum A.M., Li J., Sandor M., Lynch R., et al. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice. J Immunol 157 10 (1996) 4546-4553
35. Wahl S.M., Frazier-Jessen M., Jin W.W., Kopp J.B., Sher A., and Cheever A.W. Cytokine regulation of Schistosome-induced granuloma and fibrosis. Kidney Int 51 5 (1997) 1370-1375
36. Hoffmann K.F., Caspar P., Cheever A.W., and Wynn T.A. IFN-{gamma}, IL-12, and TNF-{alpha} are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol 161 8 (1998) 4201-4210
37. Lortat-Jacob H., Baltzer F., Desmouliere A., Peyrol S., and Grimaud J.A. Lobular - but not periovular - inhibition of collagen deposition in the liver of S. mansoni infected mice using interferon-gamma. J Hepatol 26 4 (1997) 894-903
38. Czaja M.J., Weiner F.R., Takahashi S., Giambrone M.A., van der Meide P.H., Schellekens H., et al. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10 5 (1989) 795-800
39. Kaplan M.H., Whitfield J.R., Boros D.L., and Grusby M.J. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 160 4 (1998) 1850-1856
40. Ribeiro de Jesus A., Magalhaes A., Gonzalez Miranda D., Gonzalez Miranda R., Araujo M.I., Almeida de Jesus A., et al. Association of type 2 cytokines with Hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 72 6 (2004) 3391-3397
41. Flores Villanueva P.O., Chikunguwo S.M., Harris T.S., and Stadecker M.J. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J Immunol 151 6 (1993) 3192-3198
42. James S.L., Cheever A.W., Caspar P., and Wynn T.A. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect Immunol 66 8 (1998) 3510-3518
43. Wang W.S., and Li Y.L. Studies on apoptosis and its induction in Schistosoma japonicum. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 18 5 (2000) 269-271
44. Estaquier J., Marguerite M., Sahuc F., Bessis N., Auriault C., and Ameisen J.C. Interleukin-10-mediated T cell apoptosis during the T helper type 2 cytokine response in murine Schistosoma mansoni parasite infection. Eur Cytokine Netw 8 2 (1997) 153-160
45. Wei P., Luo D.D., Xiong L.J., and Zeng L.L. Expression of hepatic Bcl-2 and Bax proteins in Schistosome-infected mice and the role of pentoxifylline. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 23 6 (2005) 441-443
46. Wolter K.G., Hsu Y.-T., Smith C.L., Nechushtan A., Xi X.-G., and Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139 5 (1997) 1281-1292
47. Yan X., Yang M., Li S., Wu L., and Lou L. Experimental studies on efficacy of levamisole in prevention from Schistosoma japonicum cercaria infection. Chin J Schistosomiasis Control 16 6 (2004) 436-439
48. Botros S.S., Hassan S.I., Ei-Nahal H.M., Azab M.E., Shaker Z.A., and Ei-Garem A. Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni. Immunopharmacol Immunotoxicol 11 4 (1989) 611-629